SILGAN HOLDINGS (SLGN) Company Report

On November 5, 2025, Silgan Holdings Inc. announced that its Board of Directors authorized a new stock repurchase program.
The company is authorized to repurchase up to an aggregate of $500 million of its common stock.
This authorization is valid through December 31, 2029, and replaces a prior authorization that had approximately $25 million remaining.

Nov 5, 2025, 9:31 PM

8-K

Silgan Announces New Stock Repurchase Authorization

SLGN

Share Buyback

Silgan Holdings Inc.'s Board of Directors has authorized a new stock repurchase program for up to $500 million of its common stock.
This authorization is effective through December 31, 2029, and replaces a prior authorization that had approximately $25 million remaining.
CEO Adam Greenlee stated that the company maintains a disciplined, returns-based approach to capital deployment.

Nov 5, 2025, 11:55 AM

Press Release

Silgan Holdings Inc. Reports Third Quarter 2025 Results

SLGN

Earnings

Guidance Update

Share Buyback

Silgan Holdings Inc. reported net sales of $2.01 billion for the third quarter of 2025, marking a 15% increase compared to $1.75 billion in the third quarter of 2024.
Net income for Q3 2025 was $113.3 million, or $1.06 per diluted share, up from $100.1 million, or $0.93 per diluted share, in the same period last year.
Adjusted net income per diluted share increased 1% to $1.22 in Q3 2025 from $1.21 in Q3 2024.
The company confirmed its 2025 free cash flow estimate of $430 million and returned over $120 million to shareholders year-to-date through share repurchases and dividends.
The Dispensing and Specialty Closures segment achieved a record adjusted EBIT of $113.5 million in Q3 2025, a 19% increase from Q3 2024, partly due to the Weener acquisition.

Oct 29, 2025, 8:30 PM

8-K

Silgan Reports Q3 2025 Financial Results and Updates 2025 Outlook

SLGN

Earnings

Guidance Update

Demand Weakening

Silgan reported Q3 2025 net sales of $2 billion, a 15% increase year-over-year, and total adjusted EBIT of $221 million, up 8%. The company delivered 10% adjusted EPS growth through the first three quarters of 2025 and returned over $120 million to shareholders through dividends and share repurchases.
The Dispensing and Specialty Closures segment saw sales increase 23% with record adjusted EBIT, driven by nearly 40% growth in dispensing product sales and 15% organic growth in fragrance volumes, despite a 5% decline in food and beverage closures volumes. Metal Containers sales grew 13% with 4% unit volume growth, including a 10% increase in pet food products. Custom Containers adjusted EBIT increased 15%.
For Q4 2025, adjusted EPS is estimated to be between $0.62 and $0.72 per diluted share, negatively impacted by lower volumes in personal care and home care, higher interest expense, and a higher tax rate. Full year 2025 free cash flow guidance is maintained at approximately $430 million, a 10% increase from the prior year.

Oct 29, 2025, 3:00 PM

Transcript

Silgan Holdings Reports Strong Q3 2025 Results, Adjusts Q4 Outlook

SLGN

Earnings

Guidance Update

Share Buyback

Silgan Holdings reported Q3 2025 net sales of $2 billion, a 15% increase year-over-year, with total adjusted EBIT rising 8% to $221 million and adjusted EPS at $1.22. The Dispensing and Specialty Closures segment was a strong performer, with sales up 23% and adjusted EBIT up 19%, driven by the Vayner acquisition and 15% organic growth in fragrance volumes.
For Q4 2025, the company forecasts adjusted EPS between $0.62 and $0.72, citing headwinds from higher interest expense, a higher tax rate, and an estimated $25 million impact due to lower volumes and proactive inventory reductions in the dispensing and specialty closures and custom containers segments.
Despite the Q4 adjustments, Silgan maintains its full-year 2025 free cash flow estimate of approximately $430 million, representing a 10% increase from the prior year, largely attributed to these inventory reductions. The company also anticipates higher earnings and free cash flow in 2026 and repurchased $60 million of shares in Q3 2025.

Oct 29, 2025, 3:00 PM

Transcript

Silgan Holdings Reports Q3 2025 Results and Updates 2025 Outlook

SLGN

Earnings

Guidance Update

Demand Weakening

Silgan Holdings reported Q3 2025 net sales of $2 billion, a 15% increase from the prior year, and adjusted EBIT of $221 million, an 8% increase. Adjusted EPS for the quarter was $1.22.
For the first three quarters of 2025, the company achieved 10% adjusted EPS growth and returned over $120 million in cash to shareholders through dividends and share repurchases.
The company is adjusting its Q4 2025 adjusted EPS outlook to a range of $0.62-$0.72 per diluted share, primarily due to higher interest expense, a higher tax rate, and anticipated lower volumes in dispensing and specialty closures and custom container segments for certain personal care and home care products.
For the full year 2025, Silgan expects a high single-digit % increase in total adjusted EBIT, with Dispensing and Specialty Closures adjusted EBIT projected to increase approximately 15%, Custom Containers adjusted EBIT up approximately $10 million, and Metal Containers adjusted EBIT also improving by approximately $10 million year-over-year.
Silgan maintains its free cash flow estimate of approximately $430 million for 2025, a 10% increase from the prior year, and anticipates capital expenditures of approximately $300 million. The company also expects higher earnings and free cash flow in 2026.

Oct 29, 2025, 3:00 PM

Transcript

Silgan Holdings Reports Strong Q3 2025 Results and Revises Full-Year Guidance

SLGN

Earnings

Guidance Update

Debt Issuance

Silgan Holdings Inc. reported net sales of $2.01 billion and net income of $113.3 million, or $1.06 per diluted share, for the third quarter of 2025, compared to net sales of $1.75 billion and net income of $100.1 million, or $0.93 per diluted share, in the third quarter of 2024.
The company achieved its sixth consecutive quarter of record Dispensing and Specialty Closures adjusted EBIT and realized mid-teen percentage organic growth in dispensing volumes for fragrance markets.
Silgan returned over $120 million to shareholders year-to-date through share repurchases and dividends.
For the full year 2025, the company confirmed its free cash flow estimate of $430 million but revised its adjusted net income per diluted share estimate to a range of $3.66 to $3.76, down from a previous range of $3.85 to $4.05. This revision is primarily due to lower volume expectations for certain products, a higher anticipated tax rate, and increased interest expense related to a recent euro bond issuance.

Oct 29, 2025, 10:55 AM

Press Release

Silgan Holdings Inc. Issues €600 Million Senior Notes Due 2031

SLGN

Debt Issuance

Silgan Holdings Inc. (SLGN) completed the issuance and sale of €600 million aggregate principal amount of 4¼% Senior Notes due 2031 on September 12, 2025.
The notes were sold at 100 percent of their principal amount, generating approximately €592.8 million in net proceeds after deducting discounts and estimated offering expenses.
The net proceeds were used to repay outstanding revolving loan borrowings under the Company’s senior secured credit facility.
These senior unsecured notes bear interest at 4¼% per annum, payable semiannually beginning February 15, 2026, and mature on February 15, 2031.
The company has the right to redeem the notes, in whole or in part, on or after September 15, 2027, initially at 102.125% of their principal amount, declining annually to 100% on or after September 15, 2029.

Sep 18, 2025, 8:30 PM

8-K

Silgan Prices New Senior Notes Offering

SLGN

Debt Issuance

Silgan Holdings Inc. priced a private offering of €600 million aggregate principal amount of 4¼% Senior Notes due 2031 at 100 percent of their principal amount.
The new notes will mature on February 15, 2031, with interest payable semi-annually commencing February 15, 2026.
Silgan intends to use the net proceeds from the notes to repay outstanding revolving loans under its senior secured credit facility and for other general corporate purposes.
The notes are offered only to qualified institutional buyers under Rule 144A and outside the United States in compliance with Regulation S, and will not be available to retail investors.

Sep 3, 2025, 8:30 PM

Press Release

Filings & Transcripts

View All Documents

Recent SEC filings and earnings call transcripts for SLGN.

No recent filings or transcripts found for SLGN.